SBP GROUP1177.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, SBP GROUP (1177.HK) trades at a P/E of 34.20x, P/B of 2.61x, P/S of 2.54x, and a dividend yield of 2.28%.
Longitudinal percentile comparison: P/E sits at the 70th percentile over the trailing 10Y window (vs. 71st percentile over 3Y); P/B sits at the 35th percentile over the trailing 10Y window (vs. 59th percentile over 3Y); P/S sits at the 30th percentile over the trailing 10Y window (vs. 57th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 73rd percentile within its industry and the 85th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.83%, ranking at the 75th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 34.5 points apart — worth checking the full percentile matrix on this page for the complete picture. The P/E percentile sits lower within its industry than across the market as a whole — relatively cheaper next to direct peers. Of the 2.83% total shareholder yield, 2.28% is paid out as dividends and roughly 0.55% is implied to come from buybacks — both channels are meaningfully in play. SBP GROUP operates in the Biomedical II sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 1177 · SEHK: 1177 · 1177
Want the full picture on whether SBP GROUP (1177.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 34.20 | ||||||
| P/B (MRQ) | 2.61 | ||||||
| P/S (TTM) | 2.54 | ||||||
| Dividend Yield | 2.28% | ||||||
| Buyback + Div Yield | 2.83% |